Completed PHASE4 INTERVENTIONAL NCT01024218

Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle

An Open-label, Multicenter, Handling Test and Prospective Cross-over Study on Nurse/Health Assistants Preference Between NovoFine® Autocover™ and 8 mm NovoFine® Needle

Sponsor: Novo Nordisk A/S

Conditions Delivery Systems Diabetes Healthcare Professionals

Interventions NovoFine® needle 8 mm autocover needle

Updated 8 times since 2017 Last updated: Feb 22, 2017 Started: Dec 1, 2004 Primary completion: Apr 26, 2005 Completion: Apr 26, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Delivery Systems and Diabetes and is currently completed. Novo Nordisk A/S leads this study, which shows 8 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Mar 2017 — Jun 2018 [monthly]

Completed PHASE4
Feb 2017 — Mar 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novo Nordisk A/S

Data source: Novo Nordisk A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark